KDM5B and cancer: Enkhbaatar et al. [139] observed that KDM5B, a histone H3K4 demethylase, represses the expression of the miR-200 family in cancer cells by changing the methylation status of its regulatory regions thus facilitating the EMT process and cancer progression.